Kiromic BiopharmaInc Buy Hold or Sell Recommendation
| KRBPDelisted Stock | USD 1.45 0.00 0.00% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Kiromic BiopharmaInc is 'Not Rated'. Macroaxis provides Kiromic BiopharmaInc buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding KRBP positions. The advice algorithm takes into account all of Kiromic BiopharmaInc's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Kiromic BiopharmaInc's buy or sell advice are summarized below:
Real Value 1.38 | Hype Value 1.45 | Market Value 1.45 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Kiromic BiopharmaInc given historical horizon and risk tolerance towards Kiromic BiopharmaInc. When Macroaxis issues a 'buy' or 'sell' recommendation for Kiromic BiopharmaInc, the advice is generated through an automated system that utilizes algorithms and statistical models.
Kiromic |
Execute Kiromic BiopharmaInc Buy or Sell Advice
The Kiromic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Kiromic BiopharmaInc. Macroaxis does not own or have any residual interests in Kiromic BiopharmaInc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Kiromic BiopharmaInc's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Kiromic BiopharmaInc Trading Alerts and Improvement Suggestions
| Kiromic BiopharmaInc is not yet fully synchronised with the market data | |
| Kiromic BiopharmaInc may become a speculative penny stock | |
| Kiromic BiopharmaInc has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (34.73 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Kiromic BiopharmaInc currently holds about 6.51 M in cash with (23.75 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.41. | |
| Roughly 68.0% of the company shares are owned by institutional investors |
Kiromic BiopharmaInc current analysts advice
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kiromic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kiromic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
The consensus estimates and target price estimation comprises individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.
Kiromic BiopharmaInc Returns Distribution Density
The distribution of Kiromic BiopharmaInc's historical returns is an attempt to chart the uncertainty of Kiromic BiopharmaInc's future price movements. The chart of the probability distribution of Kiromic BiopharmaInc daily returns describes the distribution of returns around its average expected value. We use Kiromic BiopharmaInc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Kiromic BiopharmaInc returns is essential to provide solid investment advice for Kiromic BiopharmaInc.
| Mean Return | -0.95 | Value At Risk | -8.23 | Potential Upside | 6.78 | Standard Deviation | 4.92 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Kiromic BiopharmaInc historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Kiromic BiopharmaInc Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Kiromic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.67 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.97 | |||
| Day Typical Price | 1.13 | |||
| Market Facilitation Index | 0.97 | |||
| Price Action Indicator | 0.49 |
About Kiromic BiopharmaInc Buy or Sell Advice
When is the right time to buy or sell Kiromic BiopharmaInc? Buying financial instruments such as Kiromic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Kiromic BiopharmaInc in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Russia On Wall Street Thematic Idea Now
Russia On Wall Street
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. The Russia On Wall Street theme has 23 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Russia On Wall Street Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. Note that the Kiromic BiopharmaInc information on this page should be used as a complementary analysis to other Kiromic BiopharmaInc's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Consideration for investing in Kiromic Stock
If you are still planning to invest in Kiromic BiopharmaInc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kiromic BiopharmaInc's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |